Alzheimer's disease pathology in APOE transgenic mouse models: The Who, What, When, Where, Why, and How is a research paper published in Neurobiology of Disease (2020). On theSindex it has a DataRank of 0. It has been cited 78 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 5UL1TR002003-08
Clinical and Translational Science Award
National Institutes of Health
Grant: 5R01AG057008-02
Estrogen therapy and APOE4 risk in Alzheimer's tested in female EFAD mice
National Institutes of Health
Grant: 4R44AG060826-02
CS6253 development for the treatment of apoE4 driven dementia includingAlzheimer's disease
National Institutes of Health
Grant: 5T32AG057468-02
Training program in the biology and translational research on Alzheimer's disease and related dementias
National Institutes of Health
Grant: 1R56AG058655-01A1
Characterization of protective roles of ApoE2 against aging and Alzheimer's disease
FWCI
4.97
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of MMP9 modulation improves specific neurobehavioral deficits in a mouse model of Alzheimer’s disease
Additional file 1 of MMP9 modulation improves specific neurobehavioral deficits in a mouse model of Alzheimer’s disease
Additional file 12 of Impact of APOE genotype on prion-type propagation of tauopathy
Additional file 12 of Impact of APOE genotype on prion-type propagation of tauopathy
Additional file 1 of A novel apoE-mimetic increases brain apoE levels, reduces Aβ pathology and improves memory when treated before onset of pathology in male mice that express APOE3
Additional file 1 of A novel apoE-mimetic increases brain apoE levels, reduces Aβ pathology and improves memory when treated before onset of pathology in male mice that express APOE3
Additional file 4 of A novel apoE-mimetic increases brain apoE levels, reduces Aβ pathology and improves memory when treated before onset of pathology in male mice that express APOE3
Additional file 3 of A novel apoE-mimetic increases brain apoE levels, reduces Aβ pathology and improves memory when treated before onset of pathology in male mice that express APOE3
Additional file 5 of A novel apoE-mimetic increases brain apoE levels, reduces Aβ pathology and improves memory when treated before onset of pathology in male mice that express APOE3
Additional file 3 of A novel apoE-mimetic increases brain apoE levels, reduces Aβ pathology and improves memory when treated before onset of pathology in male mice that express APOE3
Additional file 5 of A novel apoE-mimetic increases brain apoE levels, reduces Aβ pathology and improves memory when treated before onset of pathology in male mice that express APOE3
Additional file 4 of A novel apoE-mimetic increases brain apoE levels, reduces Aβ pathology and improves memory when treated before onset of pathology in male mice that express APOE3
Additional file 2 of A novel apoE-mimetic increases brain apoE levels, reduces Aβ pathology and improves memory when treated before onset of pathology in male mice that express APOE3
Additional file 2 of A novel apoE-mimetic increases brain apoE levels, reduces Aβ pathology and improves memory when treated before onset of pathology in male mice that express APOE3